DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
May 19, 2020 4:42pm EDT

DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020

May 13, 2020 4:41pm EDT

DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study

May 13, 2020 4:40pm EDT

DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results

May 07, 2020 4:30pm EDT

DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020

Mar 26, 2020 9:12am EDT

DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference

Mar 23, 2020 4:35pm EDT

DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update

Mar 17, 2020 8:10am EDT

DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020

Mar 09, 2020 8:10am EDT

DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020

Feb 13, 2020 4:35pm EST

DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares

Feb 11, 2020 7:15am EST

DiaMedica Announces Pricing of Public Offering of Common Shares

  • Previous
  • 1…
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap